Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)

Misclassification of outcome in case–control studies: Methods for sensitivity analysis

(2016) Rebecca Gilbert et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

(2014) E L Turner et al.   BRITISH JOURNAL OF CANCER

Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial

(2013) Michael J Barry et al.   Clinical Trials

Blinded and uniform cause of death verification in a lung cancer CT screening trial

(2012) N. Horeweg et al.   LUNG CANCER

The National Lung Screening Trial's Endpoint Verification Process: Determining the cause of death

(2011) Pamela M. Marcus et al.   Contemporary Clinical Trials

Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials

(2010) V Paul Doria-Rose et al.   Clinical Trials

Blinded and uniform causes of death verification in cancer screening: A major influence on the outcome of a prostate cancer screening trial?

(2010) S.J. Otto et al.   EUROPEAN JOURNAL OF CANCER

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

(2010) J.A. Lane et al.   EUROPEAN JOURNAL OF CANCER

CONSORT 2010 changes and testing blindness in RCTs

(2010) Kenneth F Schulz et al.   LANCET

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

(2010) Jonas Hugosson et al.   LANCET ONCOLOGY